Media Advisory: Infrastructure Announcement in Charlottetown
CHARLOTTETOWN, PE, Aug. 10, 2021 /CNW/ - Members of the media are invited to attend an important announcement regarding new infrastructure for Prince Edward Island with Sean Casey, Member of Parliament for Charlottetown, on behalf of the Honourable Catherine McKenna, Minister of Infrastructure and Communities, the Honourable James Aylward, Minister of Transportation and Infrastructure, and Tremploy representatives.
Date:
Wednesday, August 11, 2021
Time:
1:00 p.m. ADT
Location:
Tremploy Inc.
75 Raiders Road
Charlottetown, Prince Edward Island
The event will be livestreamed on the Government of Prince Edward Island's Facebook page: https://www.facebook.com/govpe. Space onsite may be limited to ensure physical distancing is possible. Please do not attend if you feel unwell or have symptoms of COVID-19.
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...